Alert detail
FDA Approval: BENDAMUSTINE HYDROCHLORIDE (BENDAMUSTINE HYDROCHLORIDE) — Type 5 - New Formulation or New Manufacturer
What changed
New IV bendamustine formulation; verify NDC-to-J-code mapping.
Who’s affected: Hematology billing teams · Effective: July 3, 2025
Primary source: View the official CMS/MAC document ↗
Get the action steps and full analysis
This change affects 2 billing codes.
The full analysis, the revision comparison and the as-of-date version of this policy are what a partner packet carries. The source document above is free and always will be.